This video is from May 26 2011 in Argentina. It was a Investor presentation discussing partnerships with Nestle, Pepsi and other companies involving the food additive poison Senomyx in their food and poison in their drinks.
Kent Snyder CEO of Senomyx 1998 -2013
This is what was said:
“We’re going to go and research the word Senomyx, okay? Senomyx is a transnational company that creates flavor enhancement ( poison ) for products for transnational companies like Pepsi, Kraft, Nestle, Campbell’s. What they’ve been doing is that they grabbed kidney cells from human aborted fetuses. So they grab these kidney cells lines from human aborted fetuses, and in the laboratory they replicate these aborted fetuses cells and they put them in all your products.”
“What products are we talking about? Well, we’re talking about your Gatorade. Drink some aborted fetuses. Yes, seriously.”
“We’re talking about Lay’s chips ( food poison ). Yeah, that’s why they taste so good, don’t they? Pepsi products, all right? Tropicana juices, Dasani water, Minute Maid.”
“We have to not consume anything from these companies and tell them that we’re going to participate in their insane ritual.”
The amount of disgusting poison they put in American food and water is a heinous crime.
About Senomyx
Senomyx was an American biotechnology company founded in 1998 by biochemist Lubert Stryer and Paul Nevsky in San Diego, California. The company specialized in developing food additives by using proprietary taste receptor-based assay systems, claiming to have “reverse engineered” human taste and aroma receptors. It utilized (HEK293) cell lines—originally derived from kidney cells from human aborted fetuses in the 1970s—for screening flavor enhancement, which sparked ethical concerns and calls for boycotts.
Senomyx’s products functioned as flavor enhancement or modulators (e.g., bitter blockers, salt and sweet enhancers) and were classified as “artificial flavors.” Due to their use in minute quantities (less than one part per million), they were not required to be disclosed on ingredient labels and did not undergo FDA safety approval, though some received GRAS status from industry bodies.
In September 2018, Swiss flavor and fragrance company Firmenich completed the acquisition of Senomyx for approximately $73.5 million, integrating its flavor enhancement innovation technologies. Prior to the acquisition, Senomyx was publicly traded on Nasdaq under the ticker SNMX
